• Most Popular
  • Most Shared

AstraZeneca CEO says wants more outsourcing deals

Tue Apr 15, 2008 5:13am EDT

Stocks

   

LONDON, April 15 (Reuters) - AstraZeneca Plc (AZN.L) wants to strike more outsourcing deals for drug manufacturing and sees an agreement with India's Ranbaxy Laboratories Ltd (RANB.BO) as a valuable part of that process.

Stocks

Chief Executive David Brennan said on Tuesday the company aimed to stop producing active pharmaceutical ingredients (APIs) in-house altogether in the long term.

"This move is absolutely consistent with our supply chain strategy," he told reporters in a conference call.

"We have been looking to outsource our manufacturing where we can ... we have long term plans to exit all API production over the next five to 10 years."

Under a settlement of a U.S. patent dispute over AstraZeneca's top-selling ulcer drug Nexium, Ranbaxy will formulate a portion of AstraZeneca's U.S. supply of Nexium from May 2010, with the active ingredient in the drug, esomeprazole magnesium, being made from May 2009.

Brennan said the deal made good commercial sense and was "perfectly lawful". AstraZeneca will file the terms of the settlement with the Federal Trade Commission and Department of Justice, two agencies which have taken a tough line on generic drug settlement deals recently. (Reporting by Ben Hirschler)



More from Reuters

A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
OUTLOOK 2010:

Be careful what you wish for

Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

Aurora, a 20-year-old Beluga whale, swims with her newborn calf after giving birth at the Vancouver Aquarium in Vancouver, British Columbia June 7, 2009. REUTERS/Andy Clark

365 days for the doomed

From polar bears to emperor penguins, endangered species will get top online billing in 2010 during the Year of Biodiversity.  Full Article